FTC sues significant pharmacy benefit managers in excess of insulin rates The agency brought action towards Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the list cost of daily life-conserving insulin medications. Now that some electronic health startups funded through the height with https://knoxizqhy.answerblogs.com/30821190/the-healthcare-news-diaries